Top medtech companies – including Abbott Diagnostics, Roche Molecular Diagnostics, Siemens AG and Thermo Fisher Scientific – have teamed up to share information on COVID-19 diagnostic tests on a registry. The aim is to use the information to get an accurate picture of how testing is happening and mitigate any testing shortage.
Medtech industry group AdvaMed announced on 21 July that it launched the national COVID-19 diagnostic supply registry, which also includes participation by BD Diagnostics - Diagnostic Systems, bioMerieux...